Home › Trials › NCT06345690

Registry to observe outcomes for patients treated with VIA Disc NP

VIA Disc NP Registry 3.0

Observational VIVEX Biologics, Inc. · NCT06345690

This study is tracking patients who received the VIA Disc NP treatment for low back pain to see how well it works and how it affects their condition over time.

Quick facts

Study typeObservational
Enrollment500 (estimated)
Ages18 Years and up
SexAll
SponsorVIVEX Biologics, Inc. Industry-sponsored
Locations23 sites (Little Rock, Arkansas and 22 other locations)
Trial IDNCT06345690 on ClinicalTrials.gov

What this trial studies

This registry aims to collect and analyze data on patients who have received treatment with VIA Disc NP for discogenic and low back pain. It will track patterns of care and patient outcomes over time, providing valuable insights into the effectiveness of this treatment. Participants will be monitored for their responses and any changes in their condition following the injection. The data collected will help inform future treatment protocols and improve patient care.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18 and older who have received a VIA Disc NP injection within the last 90 days.

Not a fit: Patients who have not received a VIA Disc NP injection or those with contraindications to the treatment may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of VIA Disc NP's effectiveness, leading to improved treatment strategies for back pain.

How similar studies have performed: While this registry approach is common, the specific focus on VIA Disc NP is relatively novel and untested in this format.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
2. 18 years of age or older
3. Literate, able to speak and read English, and able to complete questionnaires independently
4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.

Exclusion Criteria:

1. Participant did not receive VIA Disc NP injection
2. Participant is pregnant (self-reported, no special study pregnancy testing needed).
3. Any contraindications as noted in the VIA Disc NP Instructions for Use
4. Previous treatment with VIA Disc NP

Where this trial is running

Little Rock, Arkansas and 22 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Discogenic PainBack PainBack Pain, Low
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.